Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Earnings call transcript: IRIDEX Q3 2026 misses estimates as shares sink 25%

Earnings call transcript: IRIDEX Q3 2026 misses estimates as shares sink 25%

IRIDEX reported a wider-than-expected third-quarter loss and weaker revenue for Q3 2026, sending its shares down 25.4% in after-hours trading to $0.5221. The company posted an adjusted loss of $0.08 a share, compared with analysts’ estimate for a loss of $0.02, while revenue came in at $10.2 million versus expectations of $12.98 million. The results reflected sharp weakness in international retina sales, partly offset by stronger U.S. glaucoma performance and a steep improvement in gross margin.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.

Other reports of this story

Every outlet that reported this, and when →

Read the original at investing.com →

More in Finance & Markets

Your Crypto Swap Is a Transaction. Can You Actually Prove What Happened?

TronSeven — Non-Custodial Token Swaps on TRON Network Swap TRC-20 tokens on TRON with self-custody and open-source smart contracts. Low fees, verifiable on TRONSCAN.

  • Token swap involves smart contracts and token transfers, not just interface display
  • Verify token contract address via trusted blockchain explorer like TRONSCAN
  • Understand transaction hash to independently verify execution on TRON

More from Tuesday 17 November →